Levotuss

Levodropropizine, the active ingredient in Levotuss, is an antitussive presented as an oral formulation for oral use. It suppresses non‑productive, dry coughs by acting on sensory pathways in the respiratory tract, and is available over the counter in the EU market.

GNH USA supplies Levotuss as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. All shipments are accompanied by full documentation and batch release certificates.

Levodropropizine is used as an oral antitussive to manage coughs arising from irritation of the respiratory tract. - Dry cough: reduces frequency and intensity of non‑productive cough episodes. - Post‑viral cough: helps alleviate lingering cough after upper respiratory infections. - Allergic cough: mitigates cough triggered by allergic airway irritation.

Levodropropizine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset may occur. - Diarrhea: loose stools in some users. - Dizziness: transient light‑headedness reported. - Taste alteration: temporary change in taste perception. - Headache: mild head pain. - Abdominal pain: discomfort in the stomach area.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Hepatic dysfunction: elevated liver enzymes or jaundice (rare). - Severe neutropenia: low white blood cell count (very rare). - Anaphylaxis: sudden severe allergic reaction.

When using Levodropropizine, certain precautions should be observed to ensure safe and effective therapy. - Assess patient history: confirm cough is non‑productive before use. - Avoid in known hypersensitivity: discontinue if allergic signs appear. - Monitor liver function: consider periodic tests in patients with hepatic disease. - Use with caution in the elderly: start with the lowest effective dose. - Concomitant CNS depressants: no dose adjustment needed but observe for additive sedation. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levodropropizine may interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - MAO inhibitors: risk of enhanced serotonergic effects; avoid concurrent use. - Strong CYP3A4 inhibitors: may increase plasma levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Antihistamines: additive antitussive effect may cause excessive cough suppression. - Opioid analgesics: combined central depressant effects should be monitored. - Antacids containing aluminum or magnesium: may reduce absorption of levodropropizine.